Embecta Corp. (EMBC) Faces Securities Class Action Over Alleged Concealed Material Risks to Pen Needle Revenue– HBSS
Hagens Berman announced it is investigating Embecta Corp. on behalf of investors, alleging securities laws violations related to misleading statements about pen needle revenue stability. The lawsuit references the company's prior guidance of $2.80-$3.00 EPS, which was slashed to $1.55-$1.75 after a Q2 report showed EPS falling 61% to $0.27.
Key figures
- Eps
- 0.27
- Guidance
- 2026 adjusted EPS $1.55 - $1.75, reduced from $2.80 - $3.00
- Eps decline pct
- 61
- Dividend per share
- 0.01
- Guidance cut midpoint pct
- 43
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.